Empire Genomics

News about Empire Genomics

Fluorescent in situ Hybridization (FISH) is a cytogenetic diagnostic technique that utilizes DNA fragments labeled with a fluorescent tag to highlight the location, presence, or rearrangement of genetic loci. FISH probes enable clinicians and researchers to accurately determine a specific genetic abnormality. The revelation of an abnormality can answer key questions in disease diagnosis, prognosis, and enable the selection of the ideal treatment. FISH probes also aid in drug development and biomarker validation. Empire Genomics can create custom probes using their full RP-11 library. 
Here is a sampling of gene-specific probes that Empire currently offers. If a gene you are interested in, is not listed, a customized probe can be designed for you.


Info Empire Genomics

FISH, CISH and other molecular probes.

Empire Genomics designs, manufactures and distributes more than one million clinical and custom labeled molecular probes, enabling hundreds of leading global clinical laboratories, biotechnology organizations and academic institutions to advance biomarker research, accelerate diagnoses and improve personalized treatment options for patients battling cancer and other complex diseases. The company was founded in 2006 by Norma J. Nowak, PhD, a prominent member of the Human Genome Project, to utilize innovative research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The comprehensive product portfolio inlcudes Fluorescence in Situ Hybridication (FISH) and Chromogenic in Situ Hybridization (CISH) probes that are designed and optimized for specific diseases, genes, and/or regions across the entire human or mouse genomes. 

    (280 product(s) found)

One moment please while the results are retrieved.

    (280 product(s) found)